These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8964444)

  • 1. [Bisphosphonates in the treatment concept of metastatic breast carcinoma].
    Possinger K; Flath B; Akrivakis K
    Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):M91-4. PubMed ID: 8964444
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphosphonates--role in cancer therapies.
    Mehrotra B
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current use of bisphosphonates in clinical oncology].
    Vrbanec D; Plestina S; Belev B; Unusić J; Pavlinić-Diminić V
    Lijec Vjesn; 1999; 121(9-10):296-301. PubMed ID: 19658372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bisphosphonates in anti-osteolytic therapy of metastasizing breast carcinoma].
    Diel IJ; Solomayer EF
    Zentralbl Gynakol; 1996; 118(10):582-6. PubMed ID: 8999719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pamidronate in the treatment of osteolytic bone metastases in breast cancer patients.
    Theriault R
    Br J Clin Pract Suppl; 1996 Sep; 87():8-12; discussion 13-4. PubMed ID: 8995011
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bisphosphonates in the therapy of cancer patients].
    Jantunen E; Kumpulainen E
    Duodecim; 1999; 115(1):27-32. PubMed ID: 11830857
    [No Abstract]   [Full Text] [Related]  

  • 7. Bisphosphonates and metastatic breast carcinoma.
    Lipton A
    Cancer; 2003 Feb; 97(3 Suppl):848-53. PubMed ID: 12548585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral pamidronate in the prevention and treatment of skeletal metastases in patients with breast cancer.
    van Holten-Verzantvoort AT; Papapoulos SE
    Medicina (B Aires); 1997; 57 Suppl 1():109-13. PubMed ID: 9567363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of osteonecrosis of the lower jaw due to bisphosphonates in a breast cancer patient with bone metastasis].
    Kubo N; Katayama K; Ishizaki A; Morinaga N; Negishi T; Kuwano H
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1973-5. PubMed ID: 19011355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of oral ibandronate in the treatment of metastatic bone disease in patients with breast cancer.
    Utkan G; Büyükçelik A; Yalçyn B
    Ann Oncol; 2004 Oct; 15(10):1574; author reply 1574-5. PubMed ID: 15367420
    [No Abstract]   [Full Text] [Related]  

  • 12. Bisphosphonates as adjuvant therapy.
    Shapiro CL
    Clin Adv Hematol Oncol; 2009 May; 7(5):319-20. PubMed ID: 19521319
    [No Abstract]   [Full Text] [Related]  

  • 13. Approaches to managing bone metastases from breast cancer: the role of bisphosphonates.
    Mystakidou K; Katsouda E; Stathopoulou E; Vlahos L
    Cancer Treat Rev; 2005 Jun; 31(4):303-11. PubMed ID: 16039956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of using Aredia for hypercalcemia in oncology patients].
    Lichinitser MR; Vyshinskaia GV; Kupchan DZ; Liubimova NV
    Ter Arkh; 1993; 65(9):80-1. PubMed ID: 8303606
    [No Abstract]   [Full Text] [Related]  

  • 15. Breast cancer: bisphosphonate therapy for metastatic bone disease.
    Body JJ
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6258s-6263s. PubMed ID: 17062710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biphosphonates in oncology].
    Khosravi Shahi P; Díaz Muñoz de la Espada V
    An Med Interna; 2005 Nov; 22(11):544-7. PubMed ID: 16454591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of bone metastases in breast cancer patients.
    Petrut B; Simmons C; Broom R; Trinkaus M; Clemons M
    Expert Opin Pharmacother; 2008 Apr; 9(6):937-45. PubMed ID: 18377337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer.
    Liauw W; Segelov E; Lih A; Dunleavy R; Links M; Ward R
    BMC Cancer; 2005 Jul; 5():89. PubMed ID: 16048654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
    Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE
    J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone metastases in breast carcinoma. Bisphosphonate protects from complications].
    MMW Fortschr Med; 2004 Apr; 146(14):45. PubMed ID: 15344758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.